Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mazzarello

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Bone Oncology|December 6, 2017
Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancerJ F Hilton, M Clemons, G Pond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2015
Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysisM F K Ibrahim, S Mazzarello, R Shorr, et al.
Cancer Metastasis Reviews|July 14, 2016
Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours-a reviewC Yeung, J Hilton, M Clemons, et al.
Current Oncology (Toronto, Ont.)|August 17, 2018
Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer-a survey of oncology nurses and physiciansN LeVasseur, C Stober, K Daigle, et al.
Current Oncology (Toronto, Ont.)|August 17, 2018
Perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient surveyN LeVasseur, C Stober, M Ibrahim, et al.
Journal of Bone Oncology|December 24, 2016
A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancerC L Addison, D Simos, Z Wang, et al.
Breast Cancer Research and Treatment|October 17, 2013
Preference weights for chemotherapy side effects from the perspective of women with breast cancerI Kuchuk, N Bouganim, K Beusterien, et al.
Breast Cancer Research and Treatment|December 9, 2015
A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancerC Jacobs, I Kuchuk, N Bouganim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 23, 2018
Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center studyR Fernandes, S Mazzarello, A A Joy, et al.
Cancer Treatment Reviews|July 18, 2018
Optimal sequence of adjuvant endocrine and radiation therapy in early-stage breast cancer - A systematic reviewS F McGee, S Mazzarello, J M Caudrelier, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Bone Oncology|December 6, 2017
Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancerJ F Hilton, M Clemons, G Pond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2015
Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysisM F K Ibrahim, S Mazzarello, R Shorr, et al.
Cancer Metastasis Reviews|July 14, 2016
Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours-a reviewC Yeung, J Hilton, M Clemons, et al.
Current Oncology (Toronto, Ont.)|August 17, 2018
Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer-a survey of oncology nurses and physiciansN LeVasseur, C Stober, K Daigle, et al.
Current Oncology (Toronto, Ont.)|August 17, 2018
Perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient surveyN LeVasseur, C Stober, M Ibrahim, et al.
Journal of Bone Oncology|December 24, 2016
A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancerC L Addison, D Simos, Z Wang, et al.
Breast Cancer Research and Treatment|October 17, 2013
Preference weights for chemotherapy side effects from the perspective of women with breast cancerI Kuchuk, N Bouganim, K Beusterien, et al.
Breast Cancer Research and Treatment|December 9, 2015
A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancerC Jacobs, I Kuchuk, N Bouganim, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 23, 2018
Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center studyR Fernandes, S Mazzarello, A A Joy, et al.
Cancer Treatment Reviews|July 18, 2018
Optimal sequence of adjuvant endocrine and radiation therapy in early-stage breast cancer - A systematic reviewS F McGee, S Mazzarello, J M Caudrelier, et al.
Pageof 1